|
MRPL3 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.597300E-03 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.185780E-02 |
| Normal-vs-Stage2 |
6.887700E-02 |
| Normal-vs-Stage3 |
3.018200E-04 |
| Normal-vs-Stage4 |
2.843900E-03 |
| Stage1-vs-Stage2 |
9.830000E-01 |
| Stage1-vs-Stage3 |
6.322300E-02 |
| Stage1-vs-Stage4 |
3.465600E-01 |
| Stage2-vs-Stage3 |
2.256400E-01 |
| Stage2-vs-Stage4 |
4.740600E-01 |
| Stage3-vs-Stage4 |
6.430600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.577690E-03 |
| Normal-vs-AfricanAmerican |
1.523180E-01 |
| Normal-vs-Asian |
4.220600E-03 |
| Caucasian-vs-AfricanAmerican |
4.282400E-01 |
| Caucasian-vs-Asian |
8.532600E-01 |
| AfricanAmerican-vs-Asian |
3.470200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
9.184300E-03 |
| Normal-vs-Female |
2.735700E-03 |
| Male-vs-Female |
7.848000E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.137610E-02 |
| Normal-vs-Age(41-60Yrs) |
9.627100E-04 |
| Normal-vs-Age(61-80Yrs) |
1.422500E-02 |
| Normal-vs-Age(81-100Yrs) |
3.030800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.627400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.440000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.650600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.737600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.564200E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.694400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
3.466400E-01 |
| Classical-VS-Follicular |
9.346600E-01 |
| Classical-VS-Other |
8.215600E-01 |
| Classical-VS-Normal |
8.782200E-03 |
| Tall-VS-Follicular |
4.204000E-01 |
| Tall-VS-Other |
8.060600E-01 |
| Tall-VS-Normal |
8.979900E-03 |
| Follicular-VS-Other |
8.761400E-01 |
| Follicular-VS-Normal |
4.220100E-02 |
| Other-VS-Normal |
2.234200E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.335600E-03 |
| Normal-vs-N1 |
1.377830E-03 |
| N0-vs-N1 |
4.875800E-01 |
|
|
